Clik here to view.
Harbour BioMed Announces Multi-Year Transgenic Platform Licensing Agreement...
SHANGHAI & ROTTERDAM, The Netherlands & CAMBRIDGE, Mass. Harbour BioMed announced today that it has licensed its patented H2L2 transgenic mouse platform for generating fully human...
View ArticleClik here to view.
和铂医药授权百济神州使用其全人源单克隆抗体转基因小鼠平台开发多种全人源单克隆抗体新药
中国上海，荷兰鹿特丹和美国马萨诸塞州剑桥 和铂医药（Harbour BioMed）宣布，已授权百济神州（BeiGene Ltd., NASDAQ: BGNE）, 一家处于商业化阶段的生物医药公司，专注于开发和商业化用于癌症治疗的创新型分子靶向和肿瘤免疫药物, 使用其拥有全球专利技术的H2L2转基因小鼠平台，开发全人源单克隆抗体创新药物。...
View ArticleClik here to view.
GE, Roche Enter Partnership to Develop Integrated Digital Diagnostics...
CHICAGO GE Healthcare has entered into a strategic, long-term partnership with Roche (SIX: RO, ROG; OTCQX: RHHBY) to jointly develop and co-market digital clinical decision support solutions. The...
View ArticleClik here to view.
Axonics® Sacral Neuromodulation System Receives Marketing Approval in Australia
IRVINE, Calif. Axonics Modulation Technologies, Inc. announced today that it received marketing approval from the Australian Department of Health, Therapeutic Goods Administration (TGA) for the...
View ArticleClik here to view.
和铂医药合作开发全人源抗体片段用于新一代CAR-T细胞免疫治疗
中国上海，荷兰鹿特丹和美国马萨诸塞州剑桥 (美国商业资讯)– 和铂医药今日宣布与艺妙神州医疗科技签署合作协议，开发全人源单克隆抗体片段用于新一代嵌合抗原受体T细胞（CAR-T）细胞免疫治疗。艺妙神州是一家专注于开发CAR-T疗法以治疗血液肿瘤和实体肿瘤的生物科技公司。...
View ArticleClik here to view.
Harbour BioMed Enters Agreement to Develop Fully Human Antibody Fragments for...
SHANGHAI & ROTTERDAM, The Netherlands & CAMBRIDGE, Mass. Harbour BioMed announced today that it has entered into an agreement with ImmunoChina Pharmaceuticals Co. Ltd. to develop fully human...
View ArticleClik here to view.
Guangdong Lewwin Pharmaceutical Research Institute Selects Provantis...
CONSHOHOCKEN, Pa. Instem, a leading provider of IT solutions to the global life sciences market, announced today that Guangdong Lewwin Pharmaceutical Research Institute Co., Ltd. (Guangdong Lewwin...
View ArticleClik here to view.
ゾールのPropaq Mが米国の空軍と陸軍から可搬式バイタルサインモニターとして選定される
米マサチューセッツ州チェルムズフォード （ビジネスワイヤ） — 旭化成グループ企業として医療機器と関連ソフトウエアソリューションを製造するゾール・メディカル・コーポレーションは本日、米国の空軍と陸軍に可搬式バイタルサインモニターPropaq® M（プロパックM）を納入する単独供給契約を国防補給庁から獲得したと発表しました。 共同の「最適製品」として選定されたPropaq...
View ArticleClik here to view.
美国空军和陆军选用ZOLL Propaq M作为其可部署生命体征监护仪
马萨诸塞州切尔姆斯福德 (美国商业资讯)–旭化成集团(Asahi Kasei Group)下属制造医疗器械及相关软件解决方案的公司ZOLL® Medical Corporation今天宣布收到国防部后勤署的独家合同，向美国空军及陆军提供Propaq® M可部署生命体征监护仪。 Propaq M入选为联名“优选产品”，它是一种先进的生命体征转运监护仪，功能远胜于Propaq Encore...
View ArticleClik here to view.
MabPlex Announces Xinfang Li as Vice President of Process Development
FREMONT, Calif. & YANTAI, SHANDONG, China MabPlex International, a world class CDMO for biologics, announced the appointment of Xinfang Li, Ph.D., to Vice President of Process Development. Dr....
View ArticleClik here to view.
Synapse Biomedical Inc.的TransAeris获得CE标记，这是首款获准用于治疗呼吸机所致横膈膜功能障碍(VIDD)的医疗器械
俄亥俄州欧柏林 (美国商业资讯)–神经刺激领域的创新公司、NeuRx Diaphragm Pacing System®的制造商Synapse Biomedical (www.synapsebiomedical.com)今天宣布，TransAeris™...
View ArticleClik here to view.
シナプス・バイオメディカルが人工呼吸器誘発性横隔膜萎縮（VIDD）治療の初の承認医療機器としてTransAerisのCEマーク認証を取得
米オハイオ州オバーリン （ビジネスワイヤ） —...
View ArticleClik here to view.
Gynesonics Announces Results from Pivotal IDE Trial for Incision Free...
REDWOOD CITY, Calif. Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced the results from their...
View ArticleClik here to view.
Enigma Biomedical Group Forms Australian Subsidiary To Further Research Efforts
TORONTO Enigma Biomedical Group today announced the formation of Enigma Biomedical Australia to support it’s ongoing research projects in Australia. The current research projects are for studies of...
View ArticleClik here to view.
Ferring and the Chinese Academy of Sciences Collaborate to Advance Research...
SAINT-PREX, Switzerland Ferring Pharmaceuticals and the Chinese Academy of Sciences (CAS) today announced a long-term collaboration to advance basic and translational research in reproductive...
View ArticleClik here to view.
Shiseido Acquires Breakthrough Technology from Olivo Laboratories
TOKYO & NEW YORK Shiseido Company, Limited (TOKYO:4911) (“Shiseido”), a leading global cosmetics company, announced today that its regional headquarters and consolidated subsidiary, Shiseido...
View ArticleClik here to view.
PeptiDream Announces the Appointment of Dr. Kiyofumi Kaneshiro to the...
KAWASAKI, Japan PeptiDream Inc., a Kanagawa-based biopharmaceutical company (“PeptiDream”)(TOKYO:4587) announced today, the appointment of Dr. Kiyofumi Kaneshiro to the management team at...
View ArticleClik here to view.
资生堂收购Olivo Laboratories，获得突破性技术
东京及纽约 (美国商业资讯)–全球领先的化妆品公司资生堂株式会社(TOKYO:4911)（简称“资生堂”）今天宣布其地区总部及合并子公司资生堂美洲公司（Shiseido Americas Corporation，简称“资生堂美洲”）已基本收购Olivo Laboratories, LLC（简称“Olivo”）的全部资产。Olivo是由Polaris...
View ArticleClik here to view.
GI Dynamics, Inc. Provides 2017 Review and 2018 Business Outlook
BOSTON & SYDNEY GI Dynamics®, Inc. (ASX:GID), a medical device company that is developing EndoBarrier® provides shareholders with a review of 2017 activities and its 2018 business outlook. GI...
View ArticleClik here to view.
Dr. Reddy’s to release Q3 FY18 results on January 25, 2018
HYDERABAD, India Dr. Reddy’s Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) will announce results for the Third Quarter ended December 31, 2017 on Thursday, January 25, 2018 after the Board...
View Article